These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

604 related items for PubMed ID: 17897478

  • 1. Salmeterol plus fluticasone propionate versus fluticasone propionate plus montelukast: a randomised controlled trial investigating the effects on airway inflammation in asthma.
    Pavord I, Woodcock A, Parker D, Rice L, SOLTA study group.
    Respir Res; 2007 Sep 27; 8(1):67. PubMed ID: 17897478
    [Abstract] [Full Text] [Related]

  • 2. Efficacy and tolerability of salmeterol/fluticasone propionate versus montelukast in childhood asthma: A prospective, randomized, double-blind, double-dummy, parallel-group study.
    Maspero J, Guerra F, Cuevas F, Gutierrez JP, Soto-Ramos M, Anderton S, Mechali D, Chan R, Pedersen S.
    Clin Ther; 2008 Aug 27; 30(8):1492-504. PubMed ID: 18803991
    [Abstract] [Full Text] [Related]

  • 3. Combined salmeterol/fluticasone propionate versus fluticasone propionate alone in mild asthma : a placebo-controlled comparison.
    Boonsawat W, Goryachkina L, Jacques L, Frith L.
    Clin Drug Investig; 2008 Aug 27; 28(2):101-11. PubMed ID: 18211118
    [Abstract] [Full Text] [Related]

  • 4. Cost effectiveness of fluticasone propionate plus salmeterol versus fluticasone propionate plus montelukast in the treatment of persistent asthma.
    O'Connor RD, Nelson H, Borker R, Emmett A, Jhingran P, Rickard K, Dorinsky P.
    Pharmacoeconomics; 2004 Aug 27; 22(12):815-25. PubMed ID: 15294013
    [Abstract] [Full Text] [Related]

  • 5. Management of Asthma in School age Children On Therapy (MASCOT): a randomised, double-blind, placebo-controlled, parallel study of efficacy and safety.
    Lenney W, McKay AJ, Tudur Smith C, Williamson PR, James M, Price D, MASCOT Study Group.
    Health Technol Assess; 2013 Feb 27; 17(4):1-218. PubMed ID: 23380178
    [Abstract] [Full Text] [Related]

  • 6. Inhaled salmeterol and fluticasone: a study comparing monotherapy and combination therapy in asthma.
    Pearlman DS, Stricker W, Weinstein S, Gross G, Chervinsky P, Woodring A, Prillaman B, Shah T.
    Ann Allergy Asthma Immunol; 1999 Mar 27; 82(3):257-65. PubMed ID: 10094216
    [Abstract] [Full Text] [Related]

  • 7. Addition of montelukast or salmeterol to fluticasone for protection against asthma attacks: a randomized, double-blind, multicenter study.
    Ilowite J, Webb R, Friedman B, Kerwin E, Bird SR, Hustad CM, Edelman JM.
    Ann Allergy Asthma Immunol; 2004 Jun 27; 92(6):641-8. PubMed ID: 15237766
    [Abstract] [Full Text] [Related]

  • 8. Effects of montelukast on surrogate inflammatory markers in corticosteroid-treated patients with asthma.
    Currie GP, Lee DK, Haggart K, Bates CE, Lipworth BJ.
    Am J Respir Crit Care Med; 2003 May 01; 167(9):1232-8. PubMed ID: 12456382
    [Abstract] [Full Text] [Related]

  • 9. Cost-effectiveness comparison of salmeterol/fluticasone propionate versus montelukast in the treatment of adults with persistent asthma.
    Sheth K, Borker R, Emmett A, Rickard K, Dorinsky P.
    Pharmacoeconomics; 2002 May 01; 20(13):909-18. PubMed ID: 12381242
    [Abstract] [Full Text] [Related]

  • 10. Salmeterol/fluticasone propionate via Diskus once daily versus fluticasone propionate twice daily in patients with mild asthma not previously receiving maintenance corticosteroids.
    Chuchalin A, Jacques L, Frith L.
    Clin Drug Investig; 2008 May 01; 28(3):169-81. PubMed ID: 18266402
    [Abstract] [Full Text] [Related]

  • 11. Montelukast and fluticasone compared with salmeterol and fluticasone in protecting against asthma exacerbation in adults: one year, double blind, randomised, comparative trial.
    Bjermer L, Bisgaard H, Bousquet J, Fabbri LM, Greening AP, Haahtela T, Holgate ST, Picado C, Menten J, Dass SB, Leff JA, Polos PG.
    BMJ; 2003 Oct 18; 327(7420):891. PubMed ID: 14563743
    [Abstract] [Full Text] [Related]

  • 12. Comparison of the effects of salmeterol/fluticasone propionate with fluticasone propionate on airway physiology in adults with mild persistent asthma.
    Houghton CM, Lawson N, Borrill ZL, Wixon CL, Yoxall S, Langley SJ, Woodcock A, Singh D.
    Respir Res; 2007 Jul 14; 8(1):52. PubMed ID: 17629923
    [Abstract] [Full Text] [Related]

  • 13. Differential effects of fluticasone and montelukast on allergen-induced asthma.
    Palmqvist M, Bruce C, Sjöstrand M, Arvidsson P, Lötvall J.
    Allergy; 2005 Jan 14; 60(1):65-70. PubMed ID: 15575933
    [Abstract] [Full Text] [Related]

  • 14. Initiation of maintenance therapy with salmeterol/fluticasone propionate combination therapy in moderate asthma: a comparison with fluticasone propionate.
    Rojas RA, Paluga I, Goldfrad CH, Duggan MT, Barnes N.
    J Asthma; 2007 Jan 14; 44(6):437-41. PubMed ID: 17654129
    [Abstract] [Full Text] [Related]

  • 15. Efficacy and tolerability of fluticasone propionate/salmeterol administered twice daily via hydrofluoroalkane 134a metered-dose inhaler in adolescent and adult patients with persistent asthma: a randomized, double-blind, placebo-controlled, 12-week study.
    Nathan RA, Rooklin A, Schoaf L, Scott C, Ellsworth A, House K, Dorinsky P.
    Clin Ther; 2006 Jan 14; 28(1):73-85. PubMed ID: 16490581
    [Abstract] [Full Text] [Related]

  • 16. Effect of addition of salmeterol versus doubling the dose of fluticasone propionate on specific airway resistance in children with asthma.
    Murray CS, Custovic A, Lowe LA, Aldington S, Williams M, Beasley R, Woodcock A.
    Allergy Asthma Proc; 2010 Jan 14; 31(5):415-21. PubMed ID: 20929609
    [Abstract] [Full Text] [Related]

  • 17. The salmeterol/fluticasone combination is more effective than fluticasone plus oral montelukast in asthma.
    Ringdal N, Eliraz A, Pruzinec R, Weber HH, Mulder PG, Akveld M, Bateman ED, International Study Group.
    Respir Med; 2003 Mar 14; 97(3):234-41. PubMed ID: 12645830
    [Abstract] [Full Text] [Related]

  • 18. Inhaled salmeterol/fluticasone propionate combination: a pharmacoeconomic review of its use in the management of asthma.
    Lyseng-Williamson KA, Plosker GL.
    Pharmacoeconomics; 2003 Mar 14; 21(13):951-89. PubMed ID: 12959627
    [Abstract] [Full Text] [Related]

  • 19. Effects of salmeterol and fluticasone propionate combination versus fluticasone propionate on airway function and eosinophilic inflammation in mild asthma.
    Hoshino M, Handa H, Miyazawa T.
    Allergol Int; 2009 Sep 14; 58(3):357-63. PubMed ID: 19454840
    [Abstract] [Full Text] [Related]

  • 20. Body mass index and response to asthma therapy: fluticasone propionate/salmeterol versus montelukast.
    Camargo CA, Boulet LP, Sutherland ER, Busse WW, Yancey SW, Emmett AH, Ortega HG, Ferro TJ.
    J Asthma; 2010 Feb 14; 47(1):76-82. PubMed ID: 20100025
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.